Page 35 - Read Online
P. 35

Breis et al. Neuroimmunol Neuroinflammation 2020;7:330-4           Neuroimmunology
               DOI: 10.20517/2347-8659.2020.14                              and Neuroinflammation




               Letter to Editor                                                              Open Access


               Anti-CASPR2 antibodies clinical significance and its
               main phenotypes



               Letícia Caroline Breis, Marco Antônio Machado Schlindwein, Marcus Vinicius Magno Gonçalves

               Department of Medicine, University of the Region of Joinville, Joinville, Santa Catarina 89202-207, Brazil.
               Correspondence to: Marco Antônio Machado Schlindwein, Department of Medicine, University of the Region of Joinville, Rua
               Ministro Calogenas, 439, Bucarein, Joinville, Santa Catarina 89202-207, Brazil. E-mail: marcoschlindwein02@gmail.com

               How to cite this article: Breis LC, Schlindwein MAM, Gonçalves MVM. Anti-CASPR2 antibodies clinical significance and its main
               phenotypes. Neuroimmunol Neuroinflammation 2020;7:330-4. http://dx.doi.org/10.20517/2347-8659.2020.14

               Received: 4 Feb 2020    Accepted: 7 Apr 2020    Available online: 6 Jun 2020

               Science Editor: Athanassios P. Kyritsis    Copy Editor: Jing-Wen Zhang    Production Editor: Jing Yu



               Contactin associated protein 2 (CASPR2) is cellular adhesion molecule (CAMs) part of the neuroxins
               family. It is a transmembrane protein with its C-terminal portion interacting with an ankyrin protein called
                                             [1]
               4.1B and also a PDZ binding motif .
               It is localized along the axon, especially in the synaptic terminal and in the juxta-paranodal portion in the
               node of Ranvier. It is found in neurons on the basal ganglia and other motor areas, limbic system, sensitive
               pathways, and appears richly expressed in the temporal lobe, especially in inhibitory GAD65 positive
                      [1-3]
               neurons . CASPR2 forms with Contactin-2 part of the VGKC complex, where it has the function of
                                                      [1-3]
               clustering Kv1 channels at the juxta-paranodal  [Figure 1].
                                                                                              [4]
               Antibodies against CASPR2 have been described in various forms of clinical presentation  [Figure 2],
               part of this great variation is believed to be associated with great variation in epitopes, although antibodies
               against the discoidin domain and laminin G1 are found in every patient [1,5,6] . As well the overlapping
               found between peptides of CASPR2 and LGI1 could explain the variation of phenotype when exposure
                                               [7,8]
               to the same VGKC complex antigens . Additionally the HLA DRB1*11:01 implicated in CASPR2 is not
                                 [7]
               associated with LGI1 .
               The pathogenesis in anti-CASPR2 disease is believed to occur due to a block on the interaction between
                                      [6,9]
               CASPR2 and Contactin-2  [Figure 3], and the disrupting the Kv1 channels expression. In some cases,
                                                                       [10]
               there is reduced expression such as in the dorsal root ganglia  and in others inducing an increase


                           © The Author(s) 2020. Open Access This article is licensed under a Creative Commons Attribution 4.0
                           International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use,
                sharing, adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as long
                as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license,
                and indicate if changes were made.


                                                                                                                                                       www.nnjournal.net
   30   31   32   33   34   35   36   37   38   39   40